Your browser doesn't support javascript.
loading
Distribution of Aspergillus species and prevalence of azole resistance in clinical and environmental samples from a Spanish hospital during a three-year study period.
Lucio, Jose; Alcazar-Fuoli, Laura; Gil, Horacio; Cano-Pascual, Samuel; Hernandez-Egido, Sara; Cuetara, Maria Soledad; Mellado, Emilia.
Affiliation
  • Lucio J; Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Majadahonda, Madrid, Spain.
  • Alcazar-Fuoli L; Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Majadahonda, Madrid, Spain.
  • Gil H; Center for Biomedical Research in Network in Infectious Diseases (CIBERINFEC-CB21/13/00105), Instituto de Salud Carlos III, Madrid, Spain.
  • Cano-Pascual S; Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Majadahonda, Madrid, Spain.
  • Hernandez-Egido S; Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Majadahonda, Madrid, Spain.
  • Cuetara MS; Microbiology Department, University Hospital Severo Ochoa, Leganés, Madrid, Spain.
  • Mellado E; Microbiology Department, University Hospital Severo Ochoa, Leganés, Madrid, Spain.
Mycoses ; 67(4): e13719, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38551063
ABSTRACT

BACKGROUND:

Surveillance studies are crucial for updating trends in Aspergillus species and antifungal susceptibility information.

OBJECTIVES:

Determine the Aspergillus species distribution and azole resistance prevalence during this 3-year prospective surveillance study in a Spanish hospital. MATERIALS AND

METHODS:

Three hundred thirty-five Aspergillus spp. clinical and environmental isolates were collected during a 3-year study. All isolates were screened for azole resistance using an agar-based screening method and resistance was confirmed by EUCAST antifungal susceptibility testing. The azole resistance mechanism was confirmed by sequencing the cyp51A gene and its promoter. All Aspergillus fumigatus strains were genotyped using TRESPERG analysis.

RESULTS:

Aspergillus fumigatus was the predominant species recovered with a total of 174 strains (51.94%). The rest of Aspergillus spp. were less frequent Aspergillus niger (14.93%), Aspergillus terreus (9.55%), Aspergillus flavus (8.36%), Aspergillus nidulans (5.37%) and Aspergillus lentulus (3.28%), among other Aspergillus species (6.57%). TRESPERG analysis showed 99 different genotypes, with 72.73% of the strains being represented as a single genotype. Some genotypes were common among clinical and environmental A. fumigatus azole-susceptible strains, even when isolated months apart. We describe the occurrence of two azole-resistant A. fumigatus strains, one clinical and another environmental, that were genotypically different and did not share genotypes with any of the azole-susceptible strains.

CONCLUSIONS:

Aspergillus fumigatus strains showed a very diverse population although several genotypes were shared among clinical and environmental strains. The isolation of azole-resistant strains from both settings suggest that an efficient analysis of clinical and environmental sources must be done to detect azole resistance in A. fumigatus.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aspergillosis / Aspergillus nidulans Limits: Humans Language: En Journal: Mycoses Journal subject: MICROBIOLOGIA Year: 2024 Document type: Article Affiliation country: Spain Country of publication: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aspergillosis / Aspergillus nidulans Limits: Humans Language: En Journal: Mycoses Journal subject: MICROBIOLOGIA Year: 2024 Document type: Article Affiliation country: Spain Country of publication: Germany